IL104777A - תכשירי רוקחות המכילים גורם גידול דמוי-אינסולין i - Google Patents

תכשירי רוקחות המכילים גורם גידול דמוי-אינסולין i

Info

Publication number
IL104777A
IL104777A IL10477789A IL10477789A IL104777A IL 104777 A IL104777 A IL 104777A IL 10477789 A IL10477789 A IL 10477789A IL 10477789 A IL10477789 A IL 10477789A IL 104777 A IL104777 A IL 104777A
Authority
IL
Israel
Prior art keywords
igf
insulin
subjects
infusion
day
Prior art date
Application number
IL10477789A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Priority claimed from IL8989166A external-priority patent/IL89166A0/xx
Publication of IL104777A publication Critical patent/IL104777A/he

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL10477789A 1988-02-05 1989-02-03 תכשירי רוקחות המכילים גורם גידול דמוי-אינסולין i IL104777A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88810072 1988-02-05
IL8989166A IL89166A0 (en) 1988-02-05 1989-02-03 Pharmaceutical compositions comprising insulin-like growth factor i

Publications (1)

Publication Number Publication Date
IL104777A true IL104777A (he) 1994-10-07

Family

ID=26118580

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10477789A IL104777A (he) 1988-02-05 1989-02-03 תכשירי רוקחות המכילים גורם גידול דמוי-אינסולין i

Country Status (1)

Country Link
IL (1) IL104777A (he)

Similar Documents

Publication Publication Date Title
EP0331630B1 (en) Use of igf-i for the manufacture of a preparation for treating and preventing secondary effects of hyperinsulinemia in diabetics treated with insulin
EP0327503B1 (en) Use of igf i in the manufacture of a medicament for the treatment of renal diseases
EP0500847B1 (en) Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
Radosevich et al. Effects of morphine on glucose homeostasis in the conscious dog.
US5466670A (en) Use of IGF-1
US4652548A (en) Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
AU780400B2 (en) Methods for treating diabetes
WO1997009060A1 (en) Method of treating insulin resistance
Spinas et al. Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations
US4654324A (en) Human proinsulin pharmaceutical formulations
US4652547A (en) Pharmaceutical formulations comprising human insulin and human proinsulin
Peracchi et al. Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients
Mauras Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects
Leinsköld et al. Effect of postoperative insulin‐like growth factor I supplementation on protein metabolism in humans
CA2338699A1 (en) Method of treating polycystic ovarian syndrome using igf/igfbp-3
Young et al. Changes in insulin-like growth factor (IGF)-binding proteins after IGF-I injections in noninsulin-dependent diabetics
US5948757A (en) High dose IGF-1 therapy
Kovacs et al. Hypoglycemic effects of insulin-like growth factor-1 in experimental uremia: can concomitant growth hormone administration prevent this effect?
IL104777A (he) תכשירי רוקחות המכילים גורם גידול דמוי-אינסולין i
HU193522B (en) Process for producing pharmaceutical preparations containing human proinsulin
NZ241617A (en) Treating and preventing secondary effects of hyperinsulinemia using insulin-like growth factor i (igf i) and lower than normal amounts of insulin
Calabrese et al. Improvement of artificial endocrine pancreas (Biostator; GCIIS) performance combining feedback controlled insulin administration with a pre-programmed insulin infusion
Jørgensen et al. Growth Hormone Effects on Day-to-Day Intermediary Metabolism

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed